SunTrust Robinson Humphrey analyst, Yatin Suneja, reiterated his Buy rating on shares of TG Therapeutics (NASDAQ: TGTX) on the belief ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE